Evaluation of Synergistic activity of Honey as Anti-Hyperglycemic when given with Triphala Kashaya in Pre-Diabetes.

EVALUATION OF YOGAVAHITVA OF MADHU WITH SPECIAL REFERENCE TO SAMYOGA ON ANTI- HYPERGLYCAEMIC ACTIVITY OF TRIPHALA IN PRE-DIABETES A RANDOMIZED OPEN LABELLED CONTROLLED CLINICAL STUDY - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080528

Enrollment

Registered

2025-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Pre-Diabetes irrespective of gender and Socio-Economic status will be selected. Subjects of age group 25-60 years will be selected Fasting Blood Sugar level: 100-125mg/dl Post Prandial Blood Sugar level: 140-199mg/dl HbA1c: 5.7%-6.4% Patients with pre-obese category and class 1 obesity Patients fulfilling the Diagnostic criteria with or without associated complaints of Polyuria, Polydipsia, Polyphagia, Tiredness and Weight parameter.

Exclusion criteria

Exclusion criteria: Any other systemic disorder which requires emergency management. Long term Diabetics with severe complications such as Diabetic neuropathy, Diabetic Nephropathy, Retinopathy, Ischemic Heart Disease, Gestational Diabetes, Diabetes Mellitus Type 1 and complaints related to mobility. Secondary Diabetics, Bronze Diabetes and Stage 2 hypertensives. Pregnant and Lactating Women. Patients will Liver cirrhosis, Sexually Transmitted Disorders, HIV, Pancreatitis, Hepatitis.

Design outcomes

Primary

Measure	Time frame
To Evaluate the Anti-Hyperglycaemic effect of Triphala in Pre-Diabetes. To Evaluate the Yogavahitwa of Madhu with special reference to Samyoga on Anti-Hyperglycaemic activity of Triphala in Pre-Diabetes. To compare the Anti-Hyperglycaemic effect of Triphala and Madhu mishrita Triphala with Standard Care [Diet and Exercise]Timepoint: 6-12 weeks	—

Secondary

Measure	Time frame
Fasting Blood Sugar level: 100-125mg/dl Post Prandial Blood Sugar level: 140-199mg/dl HbA1c: 5.7%-6.4% Patients fulfilling the Diagnostic criteria with or without associated complaints of Polyuria, Polydipsia, Polyphagia, Tiredness & Weight parameterTimepoint: 6 to 12 Weeks	—

Countries

India

Contacts

Public ContactDR GRAMA SRIRANGARAJU SAHANA

JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL, MYSURU, KARNATAKA

satishayurveda@gmail.com8073822295

Outcome results